The lot history records have been reviewed with special attention to the manufacturing and inspection of this product and the product was found to have met all specifications prior to shipment.As part of all complaint investigations, an attempt was made to evaluate the subject device as well as the device usage.In this case, no sample or image was provided for evaluation.Therefore, the reported event could not be reproduced.Potential factors that could have led or contributed to the reported event have been evaluated.Previous investigations of similar complaints have been reviewed.The reported event may be caused by the detachment of a deployment mechanism component caused by rough handling of the device during shipment, storage or preparation.Also a difficult vessel anatomy or insufficient flushing of the device may contribute to the reported event.In this case, no information regarding the vessel anatomy or the procedure was provided.The reported application represents an off-label use of the device and may be another contributing factor to the reported event.On the basis of the information available and as no sample was returned, a definite root cause for the reported event could not be determined.The ifu states: "visually inspect the bard e-luminexx vascular stent to verify that the device has not been damaged due to shipping or improper storage.Do not use damaged equipment." and "should unusual resistance be felt at any time during the procedure, the entire system should be removed as a single unit." the stent placement in the venous system represents an off-label use of the device; the ifu states that the device is intended for use in the treatment of iliac occlusive diseases or for the treatment of biliary strictures.
|